Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis

Diagnostic Microbiology and Infectious Disease

Volumn 60, Issue 4, 2008, Pages 381-385

  Aslan, Bahadir ^a   Serin, Mehmet Sami ^b   Aslan, Gonul ^b   Kalaci, Aydiner ^a   Yanat, Ahmet Nedim ^a   Tezcan, Seda ^b   Emekdas, Gurol ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

IgG; IgM; IL 6; Osteoarthritis; Parvovirus B19; PCR

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; OSTEOARTHRITIS; PARVOVIRUS; PRIORITY JOURNAL; SYNOVIAL FLUID; VIRUS DETECTION;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-6; MALE; MIDDLE AGED; OSTEOARTHRITIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 40749123593     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.11.003     Document Type: Article

References (31)

1. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., Christy W., Cooke T.D., Greenwald R., and Hochberg M. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 29 (1986) 1039-1049
2. Chang H., and Israel H. Analysis of inflammatory mediators in temporomandibular joint synovial fluid lavage samples of symptomatic patients and asymptomatic controls. J. Oral. Maxillofac. Surg. 63 (2005) 761-765
3. Cohen B.J., Buckley M.M., Clewley J.P., Jones V.E., Puttick A.H., and Jacoby R.K. Human parvovirus infection in an early rheumatoid and inflammatory arthritis. Ann. Rheum. Dis. 45 (1986) 832-838
4. Faden H., Gary Jr. G.W., and Anderson L.J. Chronic parvovirus B19 infection in presumably immunological healthy woman. Clin. Infect. Dis. 15 (1992) 595-597
5. Franssila R., Söderlund M., Brown C., Spaan W., Seppala I., and Hedman K. IgG subclass response to human parvovirus B19 infection. Clin. Diagn. Virol. 6 (1996) 41-49
6. Griffiths D.J., Cooke S.P., Herve C., Rigby S.P., Mallon E., Hajeer A., Lock M., Emery V., Taylor P., Pantelidis P., Bunker C.B., du Bois R., Weiss R.A., and Venables P.J. Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum. 42 (1999) 448-454
7. Harrison B., Silman A.J., Barrett E., and Symmons D. Low frequency of recent parvovirus infection in a population based cohort of patients with early inflammatory polyarthritis. Ann. Rheum. Dis. 57 (1998) 375-377
8. Hulsemann J.L., and Zeidler H. Undifferentiated arthritis in an early synovitis out-patient clinic. Clin. Exp. Rheumatol. 13 (1995) 37-43
9. Kellgren J.H., and Lawrence J.S. Radiological assessment of osteoarthritis. Ann. Rheum. Dis. 16 (1995) 494-502
10. Kerr J.R. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann. Rheum. Dis. 59 (2000) 672-683
11. Kurtzman G.J., Chen B.J., and Field A.M. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J. Clin. Invest. 84 (1989) 1114-1123
12. Linde A., Sundqvist V.A., Mathiesen T., and Wahren B. IgG subclasses to subviral components. Monogr. Allergy 23 (1988) 27-32
13. Lundqvist A., Tolfvenstam T., Bostic J., Soderlund M., and Broliden K. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow. Scand. J. Infect. Dis. 31 (1999) 11-16
14. Magro C.M., Dowood M.R., and Crowson A.N. The cutaneous manifestation of human parvovirus B19 infection. Hum. Pathol. 31 (2000) 488-497
15. Mehraein Y., Lennerz C., Ehlhardt S., Zang K.D., and Madry H. Replicative multivirus infection with cytomegalovirus, herpes simplex virus 1, and parvovirus B19, and latent Epstein-Barr virus infection in the synovial tissue of a psoriatic arthritis patient. J. Clin. Virol. 31 (2004) 25-31
16. Mitchell L.A. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis common pathway in inflammatory sequelae of human parvovirus infections?. J. Med. Virol. 67 (2002) 267-274
17. Mitchell L.A., Leong R., and Rosenke K.A. Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?. J. Med. Microbiol. 50 (2001) 627-635
18. Moffatt S., Tanaka N., Tada K., Nose M., Nakamura M., Muraoka O., Hirano T., and Sugamura K. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J. Virol. 70 (1996) 8485-8491
19. Moore T.L. Parvovirus-associated arthritis. Curr. Opin. Rheumatol. 12 (2000) 289-294
20. Nakagawa K., Brusic V., McColl G., and Harrison L.C. Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum. 40 (1997) 627-638
21. Nikkari S., Lukkainen R., Mottonen T., Meurman O., Hannonen P., and Skurnik M. Does parvovirus B19 have a role in rheumatoid arthritis?. Ann. Rheum. Dis. 53 (1994) 106-111
22. Peterlana D., Puccetti A., Beri R., Ricci M., Simeoni S., Borgato L., Scilanga L., Ceru S., Corrocher R., and Lunardi C. The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis. J. Rheumatol. 30 (2003) 1907-1910
23. Saal J.G., Steidle M., Einsele H., Muller C.A., Fritz P., and Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid. Rheumatol. Int. 12 (1992) 147-151
24. Sabella C., and Goldfarb J. Parvovirus B19 infections. Am. Fam. Physician 60 (1999) 1455-1460
25. Sehgal P.B. Interleukin-6: a regulator of plasma protein gene expression in hepatic and nonhepatic tissues. Mol. Biol. Med. 7 (1990) 117-130
26. Sifakis S., Ergazaki M., Souvinas G., Koffa M., Koumantalis E., and Spandidos D.A. Evaluation of Parvo B19, CMV and HPV viruses in human aborted material using the polymerase chain reaction technique. Eur. J. Obstet. Gynecol. Reprod. Biol. 76 (1998) 169-173
27. Söderlund M., von Essen R., Haapasaari J., Kiistala U., Kiviluoto O., and Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 12 (1997) 1063-1065
28. Speyer I., Breedveld F.C., and Dijkmans B.A. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clin. Exp. Rheumatol. 16 (1998) 576-578
29. Stahl H.D., Hubner B., Seidl B., Liebert U.G., van der Heijden I.M., Wilbrink B., Kraan M.C., Emmrich F., and Tak P.P. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann. Rheum. Dis. 59 (2000) 342-346
30. Takahashi Y., Murai C., Shibata S., Munakata Y., Ishii T., Ishii K., Saitoh T., Sawai T., Sugamura K., and Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8227-8232
31. Wilbrink B., Van der Heijden I.M., Schouls L.M., Van Embden J.D.A., Hazes J.M.W., and Breedveld F.C. Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum. 41 (1998) 535-543